The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or inhalation. A nasal COVID-19 vaccine, developed using technology from Washington ...

The team, led by Professor Navin Varadarajan, developed NanoSTING, a nasal spray that activates the ... individuals and ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Nasal vaccines could still be a powerful weapon in the fight against Covid-19 despite “disappointing” recent trial results for an AstraZeneca spray, experts say. By entering the body the same ...

Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing ... flu significantly reduced the growth of the coronavirus in a recent study on animals.

First, existing COVID-19 vaccines provide robust protection against severe disease and death ... Nasal vaccination has had a long but mixed history. In Russia, a nasal spray against influenza has been ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

“Most current COVID-19 vaccines are injected through muscle, resulting in poor vaccine-induced immunity in the nasal cavity and airway surface,” Linqi Zhang explains. “The nasal cavity is a ...

There were times when the inputs for making nasal swabs were lacking, which were then the standard method of collecting samples for testing. To identify people with COVID-19, researchers began ...

In October 2021, the Russian Health Ministry issued a permit for the Gamaleya Center to conduct phase two clinical trials of a nasal spray coronavirus vaccine MOSCOW, March 18. /TASS/. Russia’s ...